Study: NCT05352165

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FOLFIRI and standard long-term radiotherapy
Description: FOLFIRI and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FOLFIRI and standard long-term radiotherapy
Description: FOLFIRI and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: FOLFIRI and standard long-term radiotherapy
Description: FOLFIRI and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLFIRI and standard long-term radiotherapy
Description: FOLFIRI and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-FU and standard long-term radiotherapy
Description: 5-FU and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-FU and standard long-term radiotherapy
Description: 5-FU and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-FU and standard long-term radiotherapy
Description: 5-FU and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-FU and standard long-term radiotherapy
Description: 5-FU and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-FU and standard long-term radiotherapy
Description: 5-FU and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-FU and standard long-term radiotherapy
Description: 5-FU and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-FU and pembrolizumab and standard long-term radiotherapy
Description: 5-FU and pembrolizumab and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-FU and pembrolizumab and standard long-term radiotherapy
Description: 5-FU and pembrolizumab and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-FU and pembrolizumab and standard long-term radiotherapy
Description: 5-FU and pembrolizumab and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-FU and pembrolizumab and standard long-term radiotherapy
Description: 5-FU and pembrolizumab and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-FU and pembrolizumab and standard long-term radiotherapy
Description: 5-FU and pembrolizumab and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-FU and pembrolizumab and standard long-term radiotherapy
Description: 5-FU and pembrolizumab and standard long-term radiotherapy based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Other individualized treatments
Description: Other individualized treatments based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Other individualized treatments
Description: Other individualized treatments based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Other individualized treatments
Description: Other individualized treatments based on organoids drug sensitivity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Other individualized treatments
Description: Other individualized treatments based on organoids drug sensitivity